These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 7979096
1. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone. Kaddam IM, Iqbal SJ, Holland S, Wong M, Manning D. Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096 [Abstract] [Full Text] [Related]
2. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM. J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468 [Abstract] [Full Text] [Related]
3. Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate. de la Piedra C, Rapado A, Díaz Diego EM, Díaz Martín MA, Aguirre C, López Gavilanes E, Díaz Curiel M. Calcif Tissue Int; 1996 Aug; 59(2):95-9. PubMed ID: 8687976 [Abstract] [Full Text] [Related]
4. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling. Torres R, de la Piedra C, Rapado A. Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290 [Abstract] [Full Text] [Related]
5. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. Charles P, Poser JW, Mosekilde L, Jensen FT. J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367 [Abstract] [Full Text] [Related]
6. Galactosyl hydroxylysine in assessment of Paget's bone disease. Michalsky M, Stepan JJ, Wilczek H, Formankova J, Moro L. Clin Chim Acta; 1995 Jan 31; 234(1-2):101-8. PubMed ID: 7758208 [Abstract] [Full Text] [Related]
7. Bone alkaline phosphatase in Paget's disease. Deftos LJ, Wolfert RL, Hill CS. Horm Metab Res; 1991 Nov 31; 23(11):559-61. PubMed ID: 1816067 [Abstract] [Full Text] [Related]
8. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ. Calcif Tissue Int; 1986 Jan 31; 38(1):60-1. PubMed ID: 3079654 [Abstract] [Full Text] [Related]
9. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis. Torres R, de la Piedra C, Rapado A. Scand J Clin Lab Invest; 1989 May 31; 49(3):279-85. PubMed ID: 2787049 [Abstract] [Full Text] [Related]
10. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone. Castro-Errecaborde N, de la Piedra C, Rapado A, Alvarez-Arroyo MV, Torres R, Traba ML. J Clin Endocrinol Metab; 1991 Feb 31; 72(2):462-6. PubMed ID: 1991815 [Abstract] [Full Text] [Related]
11. Assessment of bone turnover in the dry period of dairy cows by measurement of plasma bone GLA protein, total plasma alkaline phosphatase activity and urinary hydroxyproline. van Mosel M, Corlett SC. Exp Physiol; 1990 Nov 31; 75(6):827-37. PubMed ID: 2271160 [Abstract] [Full Text] [Related]
12. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment. Coulton LA, Preston CJ, Couch M, Kanis JA. Arthritis Rheum; 1988 Sep 31; 31(9):1142-7. PubMed ID: 3048274 [Abstract] [Full Text] [Related]
13. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females. Weaver CM, Peacock M, Martin BR, McCabe GP, Zhao J, Smith DL, Wastney ME. J Bone Miner Res; 1997 Oct 31; 12(10):1714-20. PubMed ID: 9333133 [Abstract] [Full Text] [Related]
14. [Use of biochemical markers of bone turnover in Paget's disease of bone]. Vignot E, Meunier PJ. Ann Biol Clin (Paris); 2001 Oct 31; 59(3):309-11. PubMed ID: 11397680 [No Abstract] [Full Text] [Related]
15. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity. Alvarez L, Peris P, Pons F, Guañabens N, Herranz R, Monegal A, Bedini JL, Deulofeu R, Martínez de Osaba MJ, Muñoz-Gómez J, Ballesta AM. Arthritis Rheum; 1997 Mar 31; 40(3):461-8. PubMed ID: 9082934 [Abstract] [Full Text] [Related]
16. Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD). Ryan PJ, Sherry M, Gibson T, Fogelman I. Br J Rheumatol; 1992 Feb 31; 31(2):97-101. PubMed ID: 1371084 [Abstract] [Full Text] [Related]
17. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment. Papapoulos SE, Frolich M, Mudde AH, Harinck HI, vd Berg H, Bijvoet OL. J Clin Endocrinol Metab; 1987 Jul 31; 65(1):89-94. PubMed ID: 3495547 [Abstract] [Full Text] [Related]
18. Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone. Sharp CA, Worsfold M, Rowlands PR, Davie MW. Semin Arthritis Rheum; 1994 Feb 31; 23(4):242-3. PubMed ID: 8009239 [No Abstract] [Full Text] [Related]
19. Biochemical measurements in Paget's disease of bone. Russell RG, Colwell A, Hannon RA, Blumsohn A, al-Dehaimi AW, Assiri AM, Peel NF, Eastell R. Semin Arthritis Rheum; 1994 Feb 31; 23(4):240-1. PubMed ID: 8009238 [No Abstract] [Full Text] [Related]
20. Differential response of serum alkaline phosphatase and serum osteocalcin in Paget's osteosarcoma. Davie MW, Worsfold M, Sharp CA. Ann Clin Biochem; 1991 Mar 31; 28 ( Pt 2)():194-5. PubMed ID: 1859160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]